ALS is a rare neurodegenerative disorder characterized by progressive degeneration of upper and lower motor neurons, leading to muscle atrophy, paralysis, and death typically within 35 years after symptom onset (333348)
Eli Lilly's independent analysis confirmed these findings, identifying real products that reached patients with contamination levels that posed infection and sepsis risks when injected
Semaglutide has safety data extending beyond 5 years from cardiovascular outcomes trials, with an excellent profile
Approved under the brand names Ozempic (for type 2 diabetes) and Wegovy (for weight management), Semaglutide offers notable value by effectively supporting weight loss, reducing appetite, and increasing satiety
The expression of HO-1 in spinal cord tissue increases rapidly, aggravating ferroptosis after SCI
A healthcare provider might suggest stopping the medication or switching to an alternative